These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

425 related articles for article (PubMed ID: 31088931)

  • 61. Cannabinoid modulation of Kaposi's sarcoma-associated herpesvirus infection and transformation.
    Zhang X; Wang JF; Kunos G; Groopman JE
    Cancer Res; 2007 Aug; 67(15):7230-7. PubMed ID: 17671191
    [TBL] [Abstract][Full Text] [Related]  

  • 62. ERK1/2 and MEK1/2 induced by Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) early during infection of target cells are essential for expression of viral genes and for establishment of infection.
    Sharma-Walia N; Krishnan HH; Naranatt PP; Zeng L; Smith MS; Chandran B
    J Virol; 2005 Aug; 79(16):10308-29. PubMed ID: 16051824
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor has broad signaling effects in primary effusion lymphoma cells.
    Cannon M; Philpott NJ; Cesarman E
    J Virol; 2003 Jan; 77(1):57-67. PubMed ID: 12477810
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Kaposi's Sarcoma-associated Herpesvirus microRNA mutants modulate cancer hallmark phenotypic differences in human endothelial cells.
    Gay LA; Stribling D; Turner PC; Renne R
    J Virol; 2021 Apr; 95(10):. PubMed ID: 33568509
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Molecular mechanism and therapeutic implications of selinexor (KPT-330) in liposarcoma.
    Garg M; Kanojia D; Mayakonda A; Said JW; Doan NB; Chien W; Ganesan TS; Chuang LS; Venkatachalam N; Baloglu E; Shacham S; Kauffman M; Koeffler HP
    Oncotarget; 2017 Jan; 8(5):7521-7532. PubMed ID: 27893412
    [TBL] [Abstract][Full Text] [Related]  

  • 66. HACE1, an E3 Ubiquitin Protein Ligase, Mitigates Kaposi's Sarcoma-Associated Herpesvirus Infection-Induced Oxidative Stress by Promoting Nrf2 Activity.
    Kumar B; Roy A; Asha K; Sharma-Walia N; Ansari MA; Chandran B
    J Virol; 2019 May; 93(9):. PubMed ID: 30787155
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Kaposi's sarcoma-associated herpesvirus-induced upregulation of the c-kit proto-oncogene, as identified by gene expression profiling, is essential for the transformation of endothelial cells.
    Moses AV; Jarvis MA; Raggo C; Bell YC; Ruhl R; Luukkonen BG; Griffith DJ; Wait CL; Druker BJ; Heinrich MC; Nelson JA; Früh K
    J Virol; 2002 Aug; 76(16):8383-99. PubMed ID: 12134042
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Viral FGARAT Homolog ORF75 of Rhesus Monkey Rhadinovirus Effects Proteasomal Degradation of the ND10 Components SP100 and PML.
    Hahn AS; Großkopf AK; Jungnickl D; Scholz B; Ensser A
    J Virol; 2016 Sep; 90(17):8013-28. PubMed ID: 27356898
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Kaposi's sarcoma herpesvirus (KSHV) microRNA K12-1 functions as an oncogene by activating NF-κB/IL-6/STAT3 signaling.
    Chen M; Sun F; Han L; Qu Z
    Oncotarget; 2016 May; 7(22):33363-73. PubMed ID: 27166260
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Viral interleukin-6 encoded by an oncogenic virus promotes angiogenesis and cellular transformation by enhancing STAT3-mediated epigenetic silencing of caveolin 1.
    Li W; Wang Q; Qi X; Guo Y; Lu H; Chen Y; Lu Z; Yan Q; Zhu X; Jung JU; Tosato G; Gao SJ; Lu C
    Oncogene; 2020 Jun; 39(23):4603-4618. PubMed ID: 32393833
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Biologic activity of the novel orally bioavailable selective inhibitor of nuclear export (SINE) KPT-335 against canine melanoma cell lines.
    Breit MN; Kisseberth WC; Bear MD; Landesman Y; Kashyap T; McCauley D; Kauffman MG; Shacham S; London CA
    BMC Vet Res; 2014 Jul; 10():160. PubMed ID: 25022346
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Identification of Novel Kaposi's Sarcoma-Associated Herpesvirus Orf50 Transcripts: Discovery of New RTA Isoforms with Variable Transactivation Potential.
    Wakeman BS; Izumiya Y; Speck SH
    J Virol; 2017 Jan; 91(1):. PubMed ID: 27795414
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Identification of new antiviral agents against Kaposi's sarcoma-associated herpesvirus (KSHV) by high-throughput drug screening reveals the role of histamine-related signaling in promoting viral lytic reactivation.
    Chen J; Dai L; Goldstein A; Zhang H; Tang W; Forrest JC; Post SR; Chen X; Qin Z
    PLoS Pathog; 2019 Dec; 15(12):e1008156. PubMed ID: 31790497
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Kaposi's sarcoma-associated herpesvirus can productively infect primary human keratinocytes and alter their growth properties.
    Cerimele F; Curreli F; Ely S; Friedman-Kien AE; Cesarman E; Flore O
    J Virol; 2001 Mar; 75(5):2435-43. PubMed ID: 11160746
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Novel inhibitors of nuclear transport cause cell cycle arrest and decrease cyst growth in ADPKD associated with decreased CDK4 levels.
    Tan M; Wettersten HI; Chu K; Huso DL; Watnick T; Friedlander S; Landesman Y; Weiss RH
    Am J Physiol Renal Physiol; 2014 Dec; 307(11):F1179-86. PubMed ID: 25234309
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Kaposi's Sarcoma-Associated Herpesvirus Increases PD-L1 and Proinflammatory Cytokine Expression in Human Monocytes.
    Host KM; Jacobs SR; West JA; Zhang Z; Costantini LM; Stopford CM; Dittmer DP; Damania B
    mBio; 2017 Oct; 8(5):. PubMed ID: 29018115
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Kaposi's sarcoma herpesvirus-induced endothelial cell reprogramming supports viral persistence and contributes to Kaposi's sarcoma tumorigenesis.
    Gramolelli S; Ojala PM
    Curr Opin Virol; 2017 Oct; 26():156-162. PubMed ID: 29031103
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Altered Nuclear Export Signal Recognition as a Driver of Oncogenesis.
    Taylor J; Sendino M; Gorelick AN; Pastore A; Chang MT; Penson AV; Gavrila EI; Stewart C; Melnik EM; Herrejon Chavez F; Bitner L; Yoshimi A; Lee SC; Inoue D; Liu B; Zhang XJ; Mato AR; Dogan A; Kharas MG; Chen Y; Wang D; Soni RK; Hendrickson RC; Prieto G; Rodriguez JA; Taylor BS; Abdel-Wahab O
    Cancer Discov; 2019 Oct; 9(10):1452-1467. PubMed ID: 31285298
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Simultaneous targeting of XPO1 and BCL2 as an effective treatment strategy for double-hit lymphoma.
    Liu Y; Azizian NG; Dou Y; Pham LV; Li Y
    J Hematol Oncol; 2019 Nov; 12(1):119. PubMed ID: 31752970
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Kaposi's sarcoma-associated herpesvirus-encoded latency-associated nuclear antigen induces chromosomal instability through inhibition of p53 function.
    Si H; Robertson ES
    J Virol; 2006 Jan; 80(2):697-709. PubMed ID: 16378973
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.